Dr. Jonathan Trent, Dr.
Claim this profileUniversity of Miami
Studies Cancer
Studies Gastrointestinal Stromal Tumor
6 reported clinical trials
8 drugs studied
Area of expertise
1Cancer
Stage IV
KIT positive
SMARCB1 positive
2Gastrointestinal Stromal Tumor
KIT positive
Stage IV
PDGFRA positive
Affiliated Hospitals
Clinical Trials Jonathan Trent, Dr. is currently running
Sunitinib + Regorafenib
for GIST
The purpose of this research is to test if mutations (changes in DNA) in exons (segment of DNA or RNA containing information that has the instructions for making proteins) in the KIT gene can be used to predict the body's response to standard of care treatment.
Recruiting1 award Phase 2
IDRX-42
for GIST
This trial tests IDRX-42, an oral drug designed to block proteins that help cancer grow, in adults with advanced GIST who haven't responded to other treatments. The goal is to see if the drug is safe and effective.
Recruiting1 award Phase 1
More about Jonathan Trent, Dr.
Clinical Trial Related6 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Jonathan Trent, Dr. has experience with
- Regorafenib
- Sunitinib
- FHD-609
- IDRX-42
- Botensilimab
- Anlotinib
Breakdown of trials Jonathan Trent, Dr. has run
Cancer
Gastrointestinal Stromal Tumor
Gastrointestinal Stromal Tumors
Soft Tissue Sarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jonathan Trent, Dr. specialize in?
Jonathan Trent, Dr. focuses on Cancer and Gastrointestinal Stromal Tumor. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are KIT positive.
Is Jonathan Trent, Dr. currently recruiting for clinical trials?
Yes, Jonathan Trent, Dr. is currently recruiting for 2 clinical trials in Miami Florida. If you're interested in participating, you should apply.
Are there any treatments that Jonathan Trent, Dr. has studied deeply?
Yes, Jonathan Trent, Dr. has studied treatments such as Regorafenib, Sunitinib, FHD-609.
What is the best way to schedule an appointment with Jonathan Trent, Dr.?
Apply for one of the trials that Jonathan Trent, Dr. is conducting.
What is the office address of Jonathan Trent, Dr.?
The office of Jonathan Trent, Dr. is located at: University of Miami, Miami, Florida 33136 United States. This is the address for their practice at the University of Miami.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.